May 1, 2024Open Access

Supplementary Figure S2 from Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma

View Full Paper

Ask AI

Bookmark

Abstract

Supplementary Figure S2. In vitro setup of CARTEAM to CAF:AsPC-1 with different ratios showing superiority of mesoFAP compared to CARs targeting mesothelin only.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wehrli et al. (2024) studied this question.

synapsesocial.com/papers/68e6c4bab6db6435876439fa https://doi.org/10.1158/1078-0432.25728823.v1

View Full Paper

Ask AI

Bookmark

Abstract

Supplementary Figure S2. In vitro setup of CARTEAM to CAF:AsPC-1 with different ratios showing superiority of mesoFAP compared to CARs targeting mesothelin only.

Supplementary Figure S2 from Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma

Abstract

Discussion

Cite This Study

Supplementary Figure S2 from Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma

Abstract

Discussion

Cite This Study

Keep reading

Keep reading